Biotricity (NASDAQ:BTCY) Stock Price Up 6.9% – What’s Next?

Biotricity, Inc. (NASDAQ:BTCY)’s stock price shot up 6.9% during mid-day trading on Thursday . The company traded as high as $0.33 and last traded at $0.31. 104,856 shares changed hands during trading, an increase of 37% from the average session volume of 76,434 shares. The stock had previously closed at $0.29.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reissued a “neutral” rating on shares of Biotricity in a report on Monday, November 18th.

Biotricity Stock Up 12.9 %

The firm has a market capitalization of $8.59 million, a price-to-earnings ratio of -0.26 and a beta of 1.14. The firm’s 50 day moving average is $0.32 and its 200 day moving average is $0.46.

Institutional Trading of Biotricity

An institutional investor recently bought a new position in Biotricity stock. AE Wealth Management LLC acquired a new position in shares of Biotricity, Inc. (NASDAQ:BTCY) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 97,751 shares of the company’s stock, valued at approximately $88,000. AE Wealth Management LLC owned approximately 0.45% of Biotricity as of its most recent filing with the Securities and Exchange Commission. 3.89% of the stock is owned by institutional investors.

Biotricity Company Profile

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.